216 Capital invests in HealthCare Startup eSteps

The connected health market is booming, driven by an aging population and a growing demand for personalized healthcare solutions. Revenue in this sector is expected to surge by over 60% by 2025, reaching approximately €78 billion, according to Statista.

With its smart insole capable of detecting early signs of neurodegenerative diseases, the startup eSteps aims to revolutionize the management and treatment of these conditions. The insole collects data on the user’s movements and gait, which is then analyzed by a mobile application that provides personalized insights. The device can also be used by athletes and fitness enthusiasts. Thanks to this cutting-edge technology, eSteps is well-positioned to become a major player in the connected health sector. To achieve this, the company has already established strategic partnerships with leading healthcare organizations in the United States and Europe.

eSteps originated from university research led by Nidhal Louhichi at the University of Bologna in Italy, eventually becoming a startup in 2020. The company later moved its headquarters to Boston in March 2022, positioning itself within the world’s leading digital health hub. Since then, eSteps has gained support from EXOR Ventures and 216 Capital. EXOR Ventures contributed its strategic vision for the healthcare sector, while 216 Capital facilitated eSteps' expansion into North Africa, particularly in Tunisia.

216 Capital, having invested in the startup’s early stages, highlighted the significant impact of eSteps on digital health and mobility solutions. Dhekra Khelifi, Partner at 216 Capital, stated, “We believe in the transformative potential of eSteps. Our investment in eSteps is driven by their commitment to leveraging advanced technologies to improve patient outcomes, empower healthcare professionals, and ultimately enhance the quality of life for many. eSteps’ vision aligns with our mission to support groundbreaking advancements that address critical health challenges and promote a healthier future for all.”

eSteps aspires to become the global leader in connected health for individuals with neurodegenerative diseases. The company plans to develop new products and services, including mobile applications and data platforms, to offer a comprehensive connected health experience to its users.